FDA Accepts Integral Molecular’s Membrane Proteome Array™ Qualification Plan, Advancing the Platform for Approval as a Drug Development Tool
Philadelphia – Integral Molecular, a leader in antibody discovery technologies, is proud to announce that the FDA has accepted their Membrane Proteome Array™ (MPA) […]